港股異動 | 滔搏(6110.HK)午後異動拉昇 現大漲近8%
格隆匯12月30日丨次新股滔搏(6110.HK)今日午後股價異動拉昇,持續大漲超7%。現報9.35港元,漲7.84%,暫成交1.8億港元,最新總市值579.8億港元。日前國信證券觀點稱,看好Nike核心差異化零售夥伴,共同數字化轉型的大中華區龍頭零售商,推薦滔搏。大和首次覆蓋研究滔搏國際,予其“買入”評級,目標價11.7港元。視滔搏為全球運動服裝龍頭在內地擴張的最佳代理(Nike和Adidas共佔公司2020年財年中期銷售額87.9%),以及中國消費升級的主要受惠者。日前耐克公佈二季度盈利和營收均超市場預期,大中華區實現連續22個季度雙位數增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.